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GDNF–Induced Activation
of the Ret Protein Tyrosine Kinase
Is Mediated by GDNFR-a, a Novel Receptor for GDNF
Shuqian Jing,*‖ Duanzhi Wen,†‖ Yanbin Yu,* The proto-oncogene ret encodes a receptor protein-
tyrosine kinase (PTK; Takahashi and Cooper, 1987). Pre-Paige L. Holst,* Yi Luo,† Mei Fang,* Rami Tamir,‡
vious studies have shown that ret is highly expressedLaarni Antonio,§ Zheng Hu,* Rod Cupples,†
in the developing central and peripheral nervous sys-Jean-Claude Louis,‡ Sylvia Hu,† Bruce W. Altrock,*
tems and in the excretory system of the mouse embryoand Gary M. Fox*
(Tsuzuki et al., 1995). Gain-of-function mutations in the*Department of Immunology
ret gene are associated with inherited predisposition†Department of Mammalian Cell Molecular Biology
to cancer in familial medullary thyroid carcinoma and‡Department of Neurobiology
multiple endocrine neoplasia type 2A (MEN2A) and 2B§Department of Developmental Biology
(MEN2B) (Donis-Keller et al., 1993; Hofstra et al., 1994;Amgen, Inc.
Mulligan et al., 1993; Santoro et al., 1995). Loss-of-func-Thousand Oaks, California 91320
tion mutations in ret are involved in Hirschsprung’s dis-
ease, which is characterized by the congenital absence
of parasympathetic innervation in the lower intestinalSummary
tract (Edery et al., 1994; Romeo et al., 1994). Targeted
disruption of the ret proto-oncogene in mice results inWe report the expression cloning and characterization
renal agenesis or severe dysgenesis and lack of entericof GDNFR-a, a novel glycosylphosphatidylinositol-
neurons throughout the digestive tract (Schuchardt etlinked cell surface receptor for glial cell line–derived
al., 1994). This phenotype closely resembles that ofneurotrophic factor (GDNF). GDNFR-a binds GDNF
GDNF knockout mice, suggesting that both Ret andspecifically and mediates activation of the Ret protein-
GDNF are involved in signal transduction pathways criti-tyrosine kinase (PTK). Treatment of Neuro-2a cells
cal to the development of the kidney and the entericexpressing GDNFR-a with GDNF rapidly stimulates
nervous system. In this paper, we report the isolationRet autophosphorylation. Ret is also activated by
of a novel cDNA clone for a high affinity GDNF receptortreatment with a combination of GDNF and soluble
and the elucidation of its role in mediating the GDNF–GDNFR-a in cells lacking GDNFR-a, and this effect is
induced autophosphorylation and activation of the Retblocked by a soluble Ret–Fc fusion protein. Ret activa-
receptor PTK.tionby GDNF was also observed in culturedembryonic
rat spinal cord motor neurons, a cell type that re-
Resultssponds to GDNF in vivo. A model for the stepwise
formation of a GDNF signal-transducing complex in-
Retinal Cells Respond to Low Doses of GDNFcluding GDNF, GDNFR-a, andthe Ret PTKis proposed.
and Express High Affinity GDNF Receptors
We examined cells that responded to low doses of GDNFIntroduction
as potential sources of GDNF receptor mRNA. Postnatal
day 5 mouse retinal cell cultures enriched for photore-Glial cell line–derived neurotrophic factor (GDNF) was
ceptors (more than 90%) were evaluated for the effect
initially isolated and cloned from B49, a rat glial cell line,
of GDNF treatment on cell survival. Cultures were
as a potent neurotrophic factor that enhances survival of
treated with human recombinant GDNF and fixed after
midbrain dopaminergic neurons (Lin et al., 1993). Recent
6 days, and photoreceptors were identified by immuno-
studies have indicated that this molecule exhibits a vari-
staining for arrestin, a rod-specific antigen. Treatment
ety of other biological activities, having effects on sev-
of the cultures with GDNF resulted in about a 2-fold
eral types of neurons from both the central and periph-
increase in the number of viable arrestin-positive photo-
eral nervous systems.
receptors after 6 days in culture (Figure 1A). The effect
Expression of GDNF has been observed in a number
of GDNF was maximal at 200 pg/ml, with an ED50 ofof different cell types and structures of the nervous sys-
about 30 pg/ml. In addition to promoting photoreceptor
tem. In addition, recent studies have shown that GDNF
survival, GDNF stimulated the extension of the axon-
transcripts are also expressed in peripheral organs, in- like processes found on these cells (mean neurite length
cluding postnatal testis and kidney, embryonic whisker of photoreceptors in GDNF is 68 plus or minus 20 mm,
pad, stomach, and skin. This widespread distribution compared with 27 plus or minus 18 mm in control cul-
outside the nervous system suggests a functional role tures).
in nonneuronal tissues. Recently, mice carrying targeted To confirm that retinal cells expressed GDNF recep-
null mutations in the GDNF gene werereported toexhibit tors, [125I]GDNF binding to postnatal rat photoreceptor
variousdefects in tissues derived from neural crest cells, cell cultures was examined. Cultures were incubated
in the autonomic nervous system, and in trigeminal and with [125I]GDNF in the presence or absence of unlabeled
spinal cord motor neurons (Sanchez et al., 1996). The GDNF, unbound [125I]GDNF was removed, and the
most severe defects were the absence of kidneys and amount of cell-associated radioactivity was determined.
the complete loss of enteric neurons in the digestive As shown inFigure 1B, a significant amount of [125I]GDNF
tract. bound to the cells even at ligand concentrations as low
as 30 pM, and this binding could be competed by excess
unlabeled GDNF.‖ These authors contributed equally to this work.
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postnatal rat retinal cells enriched for photoreceptors.
The library was divided into pools of 1500–2000 clones
each and screened using an expression cloning method
(Gearing et al., 1989) based on [125I]GDNF binding to the
cells expressing the cDNAs. A single positive pool was
identified and progressively subdivided to yield individ-
ual clones expressing the GDNF receptor cDNA.
Nucleotide sequence analysis of the 2138 nt rat GDNF
receptor cDNA clone revealed a single long open read-
ing frame encoding a protein of 468 amino acids (Figure
2; Genbank accession number U59486). A search of the
Genbank database using the FASTA algorithm did not
reveal significant homology to any other receptors. The
most likely initiator codon is found at nucleotide 302,
just downstream from an in-frame termination codon
and surrounded by a nucleotide context consistent with
a translation initiation site (Kozak, 1987). The predicted
polypeptide sequence of this receptor, which we have
named GDNFR-a, has an N-terminal hydrophobic do-
main with the characteristics of a secretory signal pep-
tide (von Heijne, 1986) and a C-terminal hydrophobic
region of about 20 amino acids. The absence of any
C-terminal hydrophilic region indicates a possibleglyco-
sylphosphatidylinositol (GPI) linkage of the receptor to
the membrane. Except for the presence of three poten-
tial N-linked glycosylation sites, no recognizable se-
quence or structural motifs were found. GDNFR-a is
extremely rich in cysteine (31 of the 468 amino acids)
but the spacing of these residues is not related to that
found in any of the extracellular cysteine-rich domains
of other receptors.
In order to clone the orthologous human GDNF recep-
tor, the rat cDNA clone was radiolabeled and used to
screen a cDNA library prepared from adult human sub-
stantia nigra. A group of five overlapping clones were
obtained and their nucleotide sequences determined.
The translation product predicted by the human cDNA
sequence consists of 465 amino acids and is 93%identi-
cal to rat GDNFR-a. In positions where the human and
rat amino acid sequences differ, the corresponding hu-
man amino acid is shown below the rat sequence in
Figure 2.
Recombinant GDNFR-a Binds GDNF
with High Affinity
In order to study its binding properties and molecular
characteristics, rat GDNFR-a was expressed on the sur-
face of both 293T and Neuro-2a cells. Neither 293T nor
Neuro-2a cells naturally express detectable levels of
GDNFR-a mRNA, and 293T cells express little or no Ret
Figure 1. GDNF Binds to Retinal Cells and Promotes Their Survival receptor as judged by blot hybridization analysis (our
in Culture unpublished data). Neuro-2a cells, a mouse neuro-
(A) Cultures weretreated with GDNF andimmunostained for arrestin. blastoma line, endogenously express a high level of Ret
The number of arrestin-positive cells was plotted versus GDNF dos- (Ikeda et al., 1990). 293T cells bound [125I]GDNF in a
age. Each value equals the mean plus or minus standard deviation
dose-dependent manner when transfected with the rat(n 5 3).
GDNFR-a cDNA clone, while parental 293T cells exhib-(B) Cultures were incubated with [125I]GDNF in the presence (open
ited little or no binding (Figure 3A). A cell line expressingbars) or absence (solid bars) of unlabeled GDNF, and the radioactiv-
ity associated with the cells was determined. both Ret and GDNFR-a was obtained by transfection of
Neuro-2a cells with the GDNFR-a cDNA clone. This cell
line, designated NGR-38, bound [125I]GDNF strongly, but
Expression Cloning of a Novel GDNF Receptor the parental Neuro-2a cells did not. In both 293T and
A size-selected cDNA expression library of approxi- Neuro-2a cells transfected with GDNFR-a, addition of
mately 50,000 independent clones was prepared using excess unlabeled GDNF effectively inhibited binding of
[125I]GDNF.the vector pBJ5 and mRNA isolated from cultures of
GDNF–Induced Activation of Ret Requires GDNFR-a
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Scatchard analysis of the equilibrium-binding data re-
vealed the presence of two classes of GDNF–binding
sites on both NGR-38 cells and 293T cells transfected
with GDNFR-a (Figure 3). In 293T cells transfected with
GDNFR-a, dissociation constants (Kd) were 2.3 pM for
the higher affinity class and 170 pM for the lower affinity
class. For NGR-38 cells, two similar sets of binding sites
were detected, one with a Kd of 1.5 6 0.5 pM and the
other with a Kd of 332 6 53 pM (n 5 3). These results
suggest that the presence of Ret has little or no effect
on equilibrium binding of GDNF.
GDNFR-a, a GPI–Linked Cell Surface Protein,
Mediates the Association of GDNF with Ret
When 293T cells transiently expressing GDNFR-a were
treated with [125I]GDNF, chemically cross-linked, and an-
alyzed by SDS–polyacrylamide gel electrophoresis
(SDS–PAGE), a major species of 75–80 kDa and a minor
species of approximately 150 kDa were observed (Fig-
ure 4A, lane 4). Also present were 15 kDa and 30 kDa
bands which probably represented GDNF monomer and
dimer, respectively. The 75–80 kDa and approximately
150 kDa bands were not observed when mock-
transfected 293T cells were analyzed, nor when excess
unlabeled GDNF was added to the cells expressing
GDNFR-a (Figure 4A, lanes 1–3). The broad 70–85 kDa
band (Figure 4A, lane 4) probably represents a mixture
of GDNF monomer and dimer cross-linked to heteroge-
neously glycosylated GDNFR-a. Since the mass of
GDNF was 15–30 kDa (monomer or dimer), the apparent
molecular mass of GDNFR-a was approximately 45–60
kDa. The predicted molecular mass of GDNFR-a in the
absence of glycosylation is approximately 47 kDa, sug-
gesting that the receptor is only lightly glycosylated.
The approximately 150 kDa species may represent a
dimer of the 70–85 kDa complex. Alternatively, it may
represent a cross-linked complex of GDNF, GDNFR-a,
and another unknown GDNF–binding protein or acces-
sory molecule naturally expressed in 293T cells.
Treatment of 293T cells expressing GDNFR-a with
phosphatidylinositol-specific phospholipase C (PI–PLC)
after cross-linking but before SDS–PAGE resulted in a
significant decrease in the amount of cell-bound cross-
linked 70–85 kDa product (Figure 4A, lane 6). When the
supernatant from PI–PLC–treated cells was analyzed,
however, a 70–85 kDa cross-linked product was found
in the culture media (Figure 4A, lane 8). These results
indicate that GDNFR-a is attached to the membrane of
293T cells through a GPI linkage.
The very similar phenotypes of the Ret and GDNF
knockout mice suggest that these two molecules could
share a common signal transduction pathway. There-
fore, even though there is no evidence that Ret alone
can bind GDNF, we set out to determine if Ret can
associate with GDNF in the presence of GDNFR-a.NGR-
38 cells were incubated with [125I]GDNF, treated with
Figure 2. Nucleotide and Amino Acid Sequences of the GDNF Re- cross-linking reagent, and then lysed. Lysates were
ceptor
treated with Ret-specific antibody, immunoprecipitated,
The nucleotide sequence of the rat GDNF receptor cDNA and pre- and analyzed by SDS–PAGE under reducing conditions
dicted translation product are shown. Cysteines are shown in bold-
(Figure 4B, lanes 1 and 2). Prominent cross-linked spe-face, potential N-glycosylation sites are marked with asterisks, and
cies of approximately 75 kDa and approximately 185the signal peptide and C-terminal hydrophobic region are under-
kDa were observed, with less intense bands of approxi-lined. Residues of the human GDNFR-a differing from the rat protein
are shown below the rat sequence. Dashes indicate deletions in the mately 150 kDa and approximately 250 kDa and a very
human sequence relative to rat. faint band of approximately 400 kDa (Figure 4B, lane 2).
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Figure 3. Binding of [125I]GDNF to 293T and
Neuro-2a Cells Expressing GDNFR-a
The main panels show Scatchard analyses of
[125I]GDNF binding; inserts contain the equi-
librium binding curves for (A) 293T (squares)
and 293T cells expressing GDNFR-a (circles)
and (B) Neuro-2a (squares) and NGR-38 cells
(circles) in the presence (open squares and
circles) or absence (solid squares and circles)
of unlabeled GDNF.
When immunoprecipitates were analyzed by nonreduc- GDNFR-a complex and Ret that was disrupted under
the conditions of the gel analysis. The broad band ating SDS–PAGE, the approximately 75 kDa, approxi-
mately 150 kDa, and approximately 185 kDa bands were approximately 185 kDa probably consists of one mole-
cule of Ret (170 kDa) cross-linked with [125I]GDNF. In apresent at about the same intensity as in the reducing
gel, but the amount of the approximately 400 kDa band separate experiment, a band of the same molecular
mass was observed when unlabeled GDNF was cross-increased dramatically (Figure 4B, lane 4). Also more
prominent on the nonreducing gel was the band at ap- linked to NGR-38 cells and the products examined by
immunoblotting with anti-Ret antibody (data not shown).proximately 250 kDa. Under both reducing and nonre-
ducing conditions, bands of similar molecular mass but Although the components of the approximately 400 kDa
band cannot be reliably identified, the fact that this bandof greatly reduced intensity were observed when paren-
tal Neuro-2a cells were used instead of NGR-38 (Figure is prominent only under nonreducing conditions indi-
cates that it is a disulfide-linked dimer of one or more4B, lanes 1 and 3). In all cases, no cross-linked products
were detected when excess unlabeled GDNF was added of the species observed under reducing conditions. It
is most likely a dimer of the 185 kDa species, although(our unpublished data). The approximately 75 kDa and
approximately 150 kDa species are likely to represent we cannot rule out a mixture of high molecular mass
complexes consisting of two Ret, one or two GDNFR-a,cross-linked complexes of GDNF and GDNFR-a, since
species with identical molecular masses are produced and one or two GDNF molecules. The identity of the
approximately 250 kDa band is also unknown. One pos-by cross-linking in 293T cells that do not express Ret
(Figure 4A). The fact that these complexes are im- sibility is that it represents cross-linked heterodimers of
the approximately 75 kDa (GDNF plus GDNFR-a) andmunoprecipitated by anti-Ret antibody indicates they
are products of an association between the GDNF– approximately 185 kDa (GDNF plus Ret) complexes.
GDNF–Induced Activation of Ret Requires GDNFR-a
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GDNF Stimulates Tyrosine Phosphorylation of Ret
in Neuro-2a Cells Expressing GDNFR-a
The ability of Ret to associate with GDNF in thepresence
of GDNFR-a suggests that GDNF may be the long
sought ligand of the Ret PTK receptor. In order to test
this possibility, we set out to determine if GDNF could
stimulate the autophosphorylation of Ret, the hallmark
of ligand-induced PTK activation (reviewed by Ullrich
and Schlessinger, 1990). NGR-38 cells were treated with
recombinant GDNF, lysed, and the lysates immunopre-
cipitated with anti-Ret antibody. Immunoprecipitates
were analyzed by immunoblotting using an antiphos-
photyrosine antibody. When NGR-38 cells were treated
with GDNF, a strong band was observed at 170 kDa,
indicating autophosphorylation of tyrosine residues on
the mature cell-surface form of Ret (Figure 5A). A much
weaker corresponding band was observed in GDNF–
treated Neuro-2a cells (Figure 5A). The 150 kDa species
recognized by anti-Ret but not antiphosphotyrosine an-
tibody is likely to be the intracellular precursor form of
Ret (Figure 5A). The dosage-dependent induction of Ret
autophosphorylation by GDNF in NGR-38 cells could be
detected with 50 pg/ml of GDNF, and the response was
saturated at 20–50 ng/ml of GDNF (Figure 5B). The stim-
ulation of Ret autophosphorylation by purified recombi-
nant GDNF in NGR-38 cells from 0–20 min following
treatment is shown in Figure 5C. Increased levels of Ret
autophosphorylation could be observed within 1 min of
GDNF treatment and was maximal at 10 min following
treatment.
GDNF and Soluble GDNFR-a Induce Ret
Autophosphorylation in Neuro-2A Cells
We have demonstrated that GDNFR-a is anchored to
the plasma membrane through a GPI linkage and can
be released by treatment with PI–PLC. When NGR-38
cells were incubated with PI–PLC, GDNF–induced re-
ceptor phosphorylation of Ret in these cells was abol-
ished (Figure 6A, lane 1). When conditioned medium
containing soluble GDNFR-a released by PI–PLC treat-
ment (PI–PLC/CM) of NGR-38 cells was added to paren-
tal Neuro-2a cells along with GDNF, phosphorylation of
the Ret receptor comparable to that obtained for GDNF
treatment of NGR-38 cells was observed (Figure 6B,
lanes 8 and 2). Only background levels of Ret phosphor-
ylation were observed when no GDNF was added or
when conditioned media derived from PI–PLC treatment
of Neuro-2a cells was tested (Figure 6B, lanes 3–7).
To confirm that phosphorylation induced by GDNF in
the presence of GDNFR-a represents Ret autophos-
Figure 4. Chemical Cross-Linking of [125I]GDNF to GDNFR-a and phorylation, we tested whether a Ret extracellular do-
Ret main/immunoglobulin Fc (Ret–Fc) fusion protein could
Cells were treated with [125I]GDNF, crosslinked, and analyzed by block Ret activation. Ret phosphorylation assays were
SDS–PAGE.
done using Neuro-2a as the target cell and media re-(A) Lysates of 293T (lanes 1–2) and 293T cells transfected with
moved from NGR-38 cells treated with PI–PLC as apSJA45 (lanes 3–6) in the presence (lanes 1, 3, 5) or absence (lanes
source of GDNFR-a. Mixtures including GDNF (50 ng/2, 4, 6) of unlabeled GDNF and with (lanes 5–6) or without (lanes
1–4) PI–PLC treatment after cross-linking. Lanes 7–8 show the su- ml), media containing soluble GDNFR-a, and different
pernatants from PI–PLC–treated cultures. concentrations of Ret–Fc fusion protein were incubated
(B) Immunoprecipitates of NGR-38 and Neuro-2a cells using an anti- together. Neuro-2a cells were treated with GDNF and
Ret antibody analyzed in the absence (NR) or presence (R) of
media containing soluble GDNFR-a, Ret–Fc, or the pre-
b-mercaptoethanol. Bands are marked as follows: solid triangle,
incubated mixtures, then lysed and the lysates immuno-approximately 75 kDa; open triangle, approximately 150 kDa; solid
precipitated using anti-Ret antibody. The immunopre-arrow, approximately 185 kDa; asterisk, approximately 250 kDa;
open arrow, approximately 400kDa. cipitates were analyzed by immunoblotting using an
Cell
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Figure 5. Induction of Ret Autophosphorylation by GDNF in NGR-38 Cells
Cells were treated with GDNF, immunoprecipitated with anti-Ret, and analyzed for Ret phosphorylation.
(A) Neuro-2a (lane 1) and NGR-38 cells (lanes 2–4) treated with GDNF produced by E. coli (lanes 1, 3) or CHO cells (lane 4).
(B) GDNF dose response.
(C) Kinetics of GDNF–induced Ret tyrosine phosphorylation. The phosphorylated 170 kDa Ret bands are indicated by solid arrows. The 170
kDa and 150 kDa Ret proteins are indicated by open arrows.
antiphosphotyrosine antibody. The preincubated mix- of GDNF–treated NGR-38 control cells (Figure 6C, lanes
7 and 2). When Ret–Fc fusion protein was included inture of GDNF and media containing soluble GDNFR-a
induced tyrosine phosphorylation of Ret receptors ex- the preincubated GDNF–GDNFR-a mixture, Ret phos-
phorylation was inhibited in a dose-dependent mannerpressed in Neuro-2a cells at a level comparable to that
Figure 6. Induction of Ret Autophosphorylation by GDNF and Soluble GDNFR-a
Cells were treated and analyzed for Ret autophosphorylation as described in Experimental Procedures.
(A) PI–PLC treatment of NGR-38 cells abolishes GDNF–induced Ret autophosphorylation.
(B) PI–PLC/CM obtained from NGR-38 cells mediates GDNF–induced Ret autophosphorylation.
(C) Ret–Fc fusion protein blocks GDNF–induced Ret activation mediated by the soluble GDNFR-a. The autophosphorylated 170 kDa Ret bands
are marked by solid arrows.
GDNF–Induced Activation of Ret Requires GDNFR-a
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Figure 8. A Model for GDNF Signaling Mediated by GDNFR-a and
Ret
Discussion
We have reported the cloning and characterization of a
receptor for GDNF which we call GDNFR-a. GDNFR-a
binds GDNF specifically and with high affinity but, like
CNTFR-a, is a GPI–linked cell-surface protein that lacks
a cytoplasmic domain capable of mediating transmem-
brane signaling (Davis et al., 1991). However, our data
indicates that GDNFR-a is a necessary component of
the active GDNF receptor complex. The binding and
Figure 7. Induction of Ret Autophosphorylation by GDNF in Motor
cross-linking studies demonstrate that association ofNeurons
GDNF with the Ret receptor PTK is mediated by
Embryonic rat spinal cord motor neurons were treated with GDNF
GDNFR-a.and analyzed for Ret autophosphorylation as described in Experi-
We have also demonstrated that the association ofmental Procedures. The phosphorylated Ret bands (lanes 1 and 2)
GDNF with Ret mediated by GDNFR-a results in ac-and the corresponding protein bands (lanes 3 and 4) are marked
by solid and open arrows, respectively. tivation of the Ret tyrosine kinase. GDNF is unable to
stimulate Ret autophosphorylation in cells that do not
express GDNFR-a or in cells treated with PI–PLC to(Figure 6C, lanes 8–10), indicating that Ret phosphoryla-
remove GDNFR-a. GDNF treatment of cells expressingtion is a result of a GDNF–Ret interaction mediated by
GDNFR-a rapidly induces Ret autophosphorylation in aGDNFR-a. In untreated Neuro-2a cells or in cells treated
dose- and time-dependent manner. Ret phosphoryla-
with any combination of GDNF or Ret–Fc fusion pro-
tion can also be induced by GDNF in cells that do not
tein in the absence of GDNFR-a, only background levels
express GDNFR-a if culture media containing soluble
of Ret phosphorylation were observed (Figure 6C,
GDNFR-a is added. This demonstrates that, like the a
lanes 3–6). components of the IL-6 (Taga et al., 1989) and ciliary
neurotrophic factor (CNTF) receptors (Davis et al., 1993),
GDNF Induces Autophosphorylation of Ret GDNFR-a does not need to be anchored in the cell
Expressed in Embryonic Rat Spinal membrane inorder to interact with its signal-transducing
Cord Motor Neurons component. In NGR-38 cells expressing GDNFR-a,
Spinal cord motor neurons are one of the major targets GDNF concentrations of 50 pg/ml (1.7 pM) activate the
of GDNF action in vivo (Li et al., 1995; Oppenheim et Ret tyrosine kinase, consistent with the binding constant
al., 1995). To test the ability of GDNF to induce Ret (1.5 pM) found for the high affinity GDNF–binding sites.
autophosphorylation in these cells, embryonic rat spinal The rapid induction of Ret phosphorylation by GDNF
cord motor neurons were treated with 20 ng/ml of GDNF and the ability of Ret–Fc to block autophosphorylation
followed by lysis of the cells, immunoprecipitation with suggest that Ret is being activated directly. The GDNF–
anti-Ret antibody, and analysis by immunoblotting with induced activation of Ret in cultured rat embryonic spi-
antiphosphotyrosine antibody. In lysates of cells treated nal cord motor neurons, a primary in vivo target of GDNF,
with GDNF, a band of tyrosine-phosphorylated protein demonstrates the biological relevance of the Ret–GDNF
with a molecular mass of approximately 170 kDa was interaction. As was found for NGR-38 cells, pretreatment
observed (Figure7, lane 2). No such signal was observed of the motor neurons with PI–PLC–inhibited GDNF–
with cells treated with binding buffer alone (Figure 7, induced Ret phosphorylation (unpublished data), sug-
lane 1). When the same filter was stripped and reprobed gesting that the activation of Ret by GDNF in motor
with anti-Ret antibody, bands with the same molecular neurons also requires GDNFR-a or a similar, as yet un-
mass and similar intensities appeared in both samples identified, GPI–linked receptor.
(Figure 7, lanes 3 and 4). The protein band identified Although binding of ligand to the receptor extracellu-
by antiphosphotyrosine antibody in GDNF–treated cells lar domain is the first step in the activation of other
comigrates with the band identified by anti-Ret, indicat- known receptor PTKs, we have shown that this is not
the case for GDNF and Ret. Figure 8 depicts a proposeding GDNF–stimulated autophosphorylation of Ret.
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model for the interaction of GDNF, GDNFR-a, and Ret embryonic development. The levels of GDNF expression
and the consequent activation of the Ret PTK. The initial found in many nonneuronal tissues were higher than in
event in this process is the binding of disulfide-linked the nervous system (Choi-Lundberg and Bohn, 1995;
dimeric GDNF to GDNFR-a in either monomeric or di- Trupp et al., 1995). Although expression of GDNFR-a
meric form. The two classes of binding sites observed has not been extensively studied, Northern blot analysis
when 293T cells were transfected with GDNFR-a cDNA detected the presence of high levels of the GDNFR-a
are explained by this model if GDNFR-a dimer and mRNA in the liver, brain, and kidney of adult rat and
monomer have different affinities for GDNF. Since we mouse (our unpublished data). The similarity of the ex-
do not know if dimeric GDNFR-a is in equilibrium with pression patterns of ret and GDNF in developing ner-
its monomer in the absence of GDNF or if dimerization vous system and kidney is consistent with their com-
is induced by GDNF binding, these possibilities are pre- bined action during development. Mammalian kidney
sented as alternative pathways. NGR-38 cells, which development has been postulated to result from recipro-
express both Ret and GDNFR-a, display GDNF–binding cal interactions between the metanephric mesenchyme
characteristics similar to 293T cells, which express and the ureteric bud, a branch developed from the cau-
GDNFR-a but not Ret. This implies that Ret is not in- dal part of the Wolffian duct (Saxen, 1987). While the
volved in the initial binding of GDNF to its receptor. We expression of ret has been found at the ureteric bud
propose that the active signaling complex consists of but not in the surrounding mesenchyme in developing
a disulfide-linked GDNF dimer and two GDNFR-a mole- embryos, the expression of GDNF was detected in the
cules bound to two molecules of Ret. As for other recep- metanephric cap tissue in the area subjacent to the
tor PTKs, close contact between the intracellular cata- capsule of the kidney (S. Scully, personal communica-
lytic domains of two Ret molecules is likely to result tion). These observations suggest that an interaction
in receptor autophosphorylation. The notion that Ret between GDNF and Ret is involved in the development
functions by this mechanism is supported by the fact and maturation of the ureteric structure. Further support
that the MEN2A mutation that causes steady-state di- for this hypothesis is provided by targeted disruptions
merization of Ret results in constitutive activation of the of the GDNF and ret genes, which result in very similar
Ret kinase (Santoro et al., 1995). phenotypic defects in kidney (Schuchardt et al., 1994;
An interesting feature of GDNF biology is that the Sanchez et al., 1996). Another major defect observed in
dose required to trigger a biological effect varies widely
both GDNF (2/2) and ret (2/2) knockout animals is a
among different cell types, suggesting the existence of
complete loss of the enteric neurons throughout the
both high and low affinity GDNF receptors. The affinities
digestive tract (Schuchardt et al., 1994; Sanchez et al.,
we determined for GDNF–binding sites on NGR-38 cells
1996). Hirschsprung’s disease, a genetic disorder char-are consistent with reported biologically effective doses
acterized by the congenital absence of parasympathetic
for GDNF on dopaminergic (Lin et al., 1993) and sensory
innervation in the lower intestinal tract, has also beenneurons (Buj-Bello et al., 1995). However, motor neurons
linked to loss-of-function mutations in ret (Romeo et al.,have been reported to respond to GDNF with an ED50
1994; Edery et al., 1994). A later report (Angrist et al.,of 5 fM (Henderson et al., 1994). While it is impossible
1995) indicated that, contrary to earlier observations,directly to compare binding affinity with the ED50 for
some Hirschsprung’s patients do not carry mutations ina biological response, very high affinity GDNF–binding
ret. We can now speculate that such patients may carrysites might exist on these cells. We cannot rule out the
mutations in GDNF, GDNFR-a, or some other criticalpresence of such sites on the NGR-38 cells used in our
component of this signaling pathway.experiments, since we would be unable to detect them
The nature of the GDNF receptor complex is uniqueby current methods. Other cells, such as embryonic
in that no other known tyrosine kinases require separatechick sympathetic neurons, have been reported to bind
ligand-binding components. Although a low affinity p75rat GDNF with a Kd of 1–5 nM (Trupp et al., 1995). We
nerve growth factor receptor does exist, p75 is not re-have no evidence that GDNFR-a is involved in such low
quired for either ligand binding or for activation of any ofaffinity binding, but if an orthologous receptor exists
the Trk receptors. Elucidation of the signaling pathwaysin chickens, its binding characteristics could be quite
employed by the GDNF receptor system and furtherdifferent, or it may not bind rat GDNF efficiently. Alterna-
study of the tissue distribution of its components shouldtively, low affinity binding could result from a weak direct
aid in our understanding of the function of GDNF in theinteraction between GDNF and Ret or between GDNF
development of the nervous and excretory systems.and unknown receptors related to GDNFR-a or Ret.
Expression of ret has been observed during em-
bryogenesis in many cell lineages of the developing cen-
Experimental Procedures
tral and peripheral nervous systems, including cells of
theenteric nervous system (Tsuzuki et al., 1995). Outside Retinal Cell Cultures
the nervous system, ret expression has been detected in The retinas of 5 day-old C57Bl/6 mouse or Sprague-Dawley rat
theWolffian duct, ureteric bud epithelium,and collecting (Jackson Laboratories) were dissected free of the pigment epithe-
lium, cut into 1 mm2 fragments, and placed into ice-cold phosphate-ducts of the kidney (Tsuzuki et al., 1995). Ret expression
buffered saline (PBS). The retinas were treated in 10 ml of Hank’shas also been detected in neuroblastoma cell lines de-
balanced salt solution containing 120 U of papain (Worthington) andrived from the neural crest (Ikeda et al., 1990) and from
2000 U of DNAase (Worthington) for 20 min at 378C on a rotary
surgically resected neuroblastomas (Nagao et al., 1990; platform shakerat about 200 rpm. Cells were dispersed by trituration
Takahashi and Cooper, 1987). GDNF expression has through fire-polished Pasteur pipettes, sieved through a 20 mm Nitex
been observed in both the central and peripheral ner- nylon mesh (Tetko, Inc.), and centrifuged for 5 min at 200 3 g.
The resulting cell pellet was resuspended into Hank’s balancedvous systems, as well as in nonneuronal tissues during
GDNF–Induced Activation of Ret Requires GDNFR-a
1121
salt solution containing 1% ovalbumin (Worthington) and 500 U at 48C, the slides were developed and screened by microscopy.
Clones from a positive pool were progressively subdivided into sub-of DNAase, layered on top of a 4% ovalbumin solution (in Hank’s
balanced salt solution), and centrifuged for 10 min at 500 3 g. pools and rescreened by the same method until a single positive
clone was isolated.The final pellet was resuspended in complete culture medium (1:1
mixture of Dulbecco’s modified Eagle’s medium [DMEM] and F12 To isolate the human GDNF receptor cDNA, an adult human sub-
stantia nigra cDNA library (59-stretch plus cDNA library in lgt10medium containing 2.5% heat-inactivated horse serum, B27 me-
dium supplement [GIBCO], 5 mg/ml D-glucose, 2 mM L-glutamine, phage; Clontech) was screened using the rat GDNF receptor cDNA
as a probe. The filters were prehybridized in 200 ml of 6 3 SSC, 120 mM HEPES, 2.5 mg/ml bovine insulin [Sigma], and 0.1 mg/ml
human transferrin [Sigma; 15,000 cells/ml]) and seeded in 90 ml 3 Denhardts, 0.5% SDS, 50 mg/ml salmon sperm DNA at 558C for
3.5 hr. Filters were hybridized with [32P]-labeled probe for 18 hr andaliquots into tissue-culture plates coated with polyornithine and
laminin as previously described (Louis et al., 1992). Cultures were then washed twice for 30 min each in 0.5 3 SSC, 0.1% SDS at 558C
and exposed to X-ray film overnight with an intensifying screen.treated with 10-fold serial dilutions of GDNF ranging from 10 ng/ml
to 1 pg/ml. The number of surviving photoreceptors in the culture
was determined as described below. DNA Sequencing and Sequence Analysis
DNA from positive single clones was prepared and sequenced using
an automated Applied Biosystems 373A DNA sequencer and TaqImmunocytochemical Identification of Photoreceptors
DyeDeoxy Terminator cycle sequencing kits (Applied Biosystems).Photoreceptorswere identified by immunostaining for arrestin. Cells
Comparison of the GDNF receptor sequence with available publicwere fixed for 30 min at room temperature with 4% paraformalde-
databases was performed using the FASTA (Pearson and Lipman,hyde in PBS (pH 7.4), followed by three washes in PBS. The fixed
1988) program as described in the University of Wisconsin Geneticscultures were blocked in Superblock (Pierce) containing 1% NP-
Computer Group package (Program Manual for the Wisconsin Pack-40 and incubated with a polyclonal anti-arrestin antibody directed
age, Version 8, September 1994, Genetics Computer Group).against a peptide fragment of arrestin (VFEEFARQNLKC) at a dilution
of 1:2000 in the same buffer for 1 hr at 378C. The cells were washed
three times with PBS, incubated with biotinylated goat–anti-rabbit [125I]GDNF Binding to Retinal and Transfected COS7
IgG (Vectastain kit, Vector Laboratories) at a 1:300 dilution for 1 hr or 293T Cells
at 378C, washed again with PBS, and incubated with a 1:150 dilution Binding of [125I]GDNF to rat retinal and transfected COS7 or 293T
of avidin–peroxidase for 45 min at 378C. The cells were washed cells was carried out as previously described (Jing et al., 1990).
three times with PBS and treated in a 0.1 M Tris (pH 7.4) containing Briefly, rat photoreceptor cultures were prepared and seeded 2–3
0.04% 39,39-diaminobenzidine–(HCl)4, 0.06% NiCl2, and 0.02% hy- days before the assay in 24 well Costar tissue-culture plates pre-
drogen peroxide, for 5–20 min. The number of arrestin-positive pho- coated with polyornithine and laminin at a density of 5.7 3 105 cells/
toreceptors, exhibiting a healthy phenotype with short axon-like cm2. For COS7 cells, 2 3 106 cells seeded in a 10 cm tissue-culture
processes, were counted in a 1 3 6 mm strip (approximately 20% dish on the previous day were transfected with 10–20 mg of pSJA45
of the surface area of a 6 mm well). Photoreceptors showing signs of (an expression plasmid derived from pBKRSV [Stratagene] con-
degeneration, such as vacuolated perikarya or fragmented neurites, taining the full-length GDNFR-a cDNA) using the diethylaminoethyl–
were excluded from the counts. Cell numbers were expressed as dextran–chloroquine method (Aruffo and Seed, 1987). Cells from
cells/6 mm well. each dish were removed and reseeded into 24 well Costar tissue-
culture plates 24 hr following the transfection and allowed to grow
for an additional 48 hr. Cells were then placed on ice for 5–10 min,Expression Cloning of GDNFR-a
washed once with ice-cold washing buffer, and incubated with 0.2Rat retinal cells enriched for photoreceptors were cultured as de-
ml binding buffer containing various concentrations of [125I]GDNFscribed above. Total RNA was prepared by standard methods, and
with or without 500 nM unlabeled GDNF at 48C for 4 hr. Cells werepoly A1 RNA was purified using a polyA–tract kit (Promega). Ran-
washed four times with 0.5 ml ice-cold washing buffer and lyseddom primed cDNA was synthesized from the poly A1 RNA using
with 0.5 ml of 1 M NaOH. The lysates were counted in a 1470 Wizardthe Gibco Superscript Choice System (Gibco). Column-fractionated
Automatic Gamma Counter (Wallac, Inc.).double-strand cDNA was ligated into expression plasmid vector
For some binding experiments, transiently transfected 293T cellspBJ5 (a modification of pSR; Takebe et al., 1988) and electroporated
were used. Following transfection (2 days), cells were removed frominto competent cells (DH10B; GIBCO). The transformants were ti-
dishes by 2 3 versine. Cells were pelleted, washed once with ice-tered and plated on Amp/LB plates at a density of 1500 colonies/
cold binding buffer, and resuspended in ice-cold binding buffer atplate. Colonies were scraped from each plate and collected to make
a density of 3 3 105 cells/ml. The cell suspension was divided into27 pools of 1500 independent clones each. A portion of the cells
aliquots containing 1.5 3 105 cells each. Cells were then pelletedfrom each pool was frozen in glycerol, and the remainder was used
and incubated with various concentrations of [125I]GDNF in the pres-to isolate plasmid DNA using a Qiagen tip-500 kit (Qiagen Inc.).
ence or absence of 500 nM of unlabeled GDNF at 48C for 4 hr withPurified human GDNF was derived from recombinant expression
gentle agitation. Cells werewashed four times with ice-cold washingin Escherichia coli (provided by A.Siahpush, Amgen, Inc.). [125I]GDNF
buffer and resuspended in 0.5 ml washing buffer. Aliquots (2, 0.2was prepared using this material by Amersham, Inc. COS7 cells
ml) of the suspension were counted in a gamma counter to deter-were seeded (220,000 cells/slide) on plastic slide flaskettes (Nunc)
mine the amount of [125I]GDNF associatedwith the cells. In all assays,coated with ProNectin (10 mg/ml in PBS) 1 day before transfection.
nonspecific binding was determined by using duplicate samples,For transfection, 700 ml of Opti MEMI (GIBCO) containing 2 mg cDNA
one of which contained 500 nM of unlabeled GDNF. The level ofwas mixed gently with 35 ml of diethylaminoethyl Dextran solution
nonspecific binding varied from 10%–20% of the specific binding(10 mg/ml; Sigma). Cells were washed twice with PBS and incubated
measured in the absence of unlabeled GDNF and was subtractedwith the transfection mix for 30 min at 378C in a 5% CO2 atmosphere.
from the specific binding.Following incubation, 3 ml of DMEM media containing 10% fetal
calf serum and 80 nM chloroquine (Sigma) was added to each flask-
ette. Cells were further incubated for 3.5 hr, shocked with 10% [125I]GDNF Binding to Neuro-2a Cells Expressing GDNFR-a
Neuro-2a cells (ATCC #CCL 131) were transfected with the expres-dimethyl sulfoxide in DMEM at room temperature for 2 min, washed
once with PBS, and grownin DMEM containing10% fetal calf serum. sion plasmid pSJA45 (our unpublished data) using the Calcium
Phosphate Transfection System (GIBCO/BRL). Transfected cellsAfter 48 hr, transfected cells were washed once with ice-cold wash-
ing buffer (DMEM containing 25 mM HEPES [pH 7.5]) and incubated were selected for plasmid expression by growth in 400 mg/ml G418
(Sigma). G418–resistant clones were expanded and assayed forin ice-cold binding buffer (washing buffer containing 2 mg/ml bovine
serum albumin) supplemented with 50 pM [125I]GDNF at 48C for 4 GDNFR-a expression by binding to [125I]GDNF. Cells from each clone
were seeded at 3 3 104 cells/cm2 in 24 well tissue-culture plateshr. Cells were washed six times in ice-cold washing buffer, fixed
with 2.5% glutaraldehyde at room temperature for 5 min, dehydrated (Becton-Dickinson) precoated with polyornithine. Cells were
washed once with ice-cold washing buffer (DMEM containing 25sequentially with 50% and 70% ethanol, and then dipped in NTB-2
photographic emulsion (Eastman Kodak). After 5 days of exposure mM HEPES [pH 7.5]) and then incubated with 50 pM [125I]GDNF in
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binding buffer (washing buffer plus 0.2% bovine serum albumin) at –COOH) was purchased from Santa Cruz Biotechnology. In all anti-
Ret immunoprecipitations, a mixture of both antibodies was used.48C for 4 hr, either in the presence or absence of 500 nM unlabeled
GDNF. Cells were then washed four times with ice-cold washing
buffer and lysed in 1 M NaOH. The amount of GDNFR-a expressed Immunoblotting Analysis
The autophosphorylation of Ret was examined by immunoblot anal-by individual clones was estimated by the ratio of [125I]GDNF bound
to cells in the absence and presence of unlabeled GDNF. NGR-38 ysis. Cells were seeded in 6 well tissue-culture dishes at a density
of 1.5 3 106 cells/well, 24 hr prior to use. Cells were washed once andcells, which had a binding ratio of 16:1, were chosen for further
experiments. Equilibrium binding of [125I]GDNF to NGR-38 cells was treated with various concentrations of different reagents, including
GDNF, PI–PLC,PI–PLC/CM, and Ret–Fc fusion protein.Treated cellscarried out as described above, except that concentrations of la-
were lysed in Triton X-100 lysis buffer and immunoprecipitated withbeled GDNF ranged from 0.5 pM–1 nM. In all assays, nonspecific
anti-Ret antibodies and protein A–Sepharose. Immunoprecipitatesbinding, as estimated by the amount of [125I]GDNF binding to cells
were fractionated by SDS–PAGE and transferred to nitrocellulosein the presence of 500 nM unlabeled GDNF, was subtracted from
membranes, as described by Harlow and Lane (1988). The mem-binding in the absence of unlabeled GDNF. Binding data was ana-
branes were blocked with 5% bovine serum albumin (Sigma), andlyzed by Scatchard plot.
the level of tyrosine phosphorylation of Ret was determined by
probing the membrane with an antiphosphotyrosine monoclonalChemical Cross-Linking
antibody, 4G10 (UBI), at room temperature for 2 hr. The amount ofTransfection of 293T cells was performed using the Calcium Phos-
Ret protein in each lane was determined by stripping and reprobingphate Transfection System (GIBCO/BRL) according to the instruc-
the same membrane with the anti-Ret antibody. Detection was ac-tions of the manufacturer. After transfection (2 days), cells were
complished using a sheep anti-mouse secondary antibody directlyremoved by 2 3 versine treatment, washed once, and resuspended
conjugated to horseradish peroxidase (Amersham) in conjunctionat a density of 2 3 106 cells/ml. Cells were incubated with 3 nM
with chemiluminescence reagents (ECL, Amersham).[125I]GDNF for 4 hr at 48C, washed four times, resuspended in buffer
containing 1 mM of Bis suberate (BS3 Pierce) and incubated at room
Treatment of Cells with PI–PLC and Generationtemperature for 30 min. Following three washes with Tris-buffered
of PI–PLC Treated Conditioned Mediasaline, a duplicate group of samples was treated with 0.5 U/ml
In order to release GPI–linked GDNFR-a from the cell surface, cellsof PI–PLC at 378C for 30 min. These cells were pelleted, and the
were washed once with washing buffer and then incubated with 1supernatants were collected. Cells were then washed and lysed
U/ml PI–PLC (Boehringer Mannheim) in binding buffer at 378C forwith 2 3 SDS–PAGE sample buffer. The cell lysates and thecollected
45 min. The cells were washed three times and then processed forsupernatants were resolved on a 10% SDS–PAGE under reducing
the Ret autophosphorylation assay or for cross-linking. To generateconditions.
PI–PLC–treated conditioned media (PI–PLC/CM), 8 3 106 cells wereNeuro-2a or NGR-38 cells were washed once with PBS (pH 7.1)
removed from tissue-culture dishes by treatment with 2 mM EDTAand then treated for 4 hr at 48C with 1nM or 3 nM [125I]GDNF. Follow-
in PBS at 378C for 5–10 min. Cells were washed once, resuspendeding binding, cells were washed four times and incubated at room
in 1 ml of binding buffer containing 1 U/ml of PI–PLC, and incubatedtemperature for 45 min with BS3. The cross-linking reaction was
at 378C for 45 min. The cells were pelleted, and the PI–PLC/CM wasquenched by washing the cells three times with Tris-buffered saline
collected.(pH 7.5). The cells were then lysed in Triton X-100 lysis buffer (50
mM HEPES [pH 7.5], 1% Triton X-100, 50 mM NaCl, 50 mM NaF,
Preparation of Embryonic Rat Spinal Cord Motor10 mM sodium pyrophosphate, 1% aprotinin, 1 mM phenylmethyl-
Neuron Culturessulfonyl fluoride, 0.5 mM Na3VO4). The lysates were clarified by cen- Enriched embryonic rat spinal cord motor neuron cultures weretrifugation and incubated with 8 mg/ml anti-Ret antibodies, and the
prepared from entire spinal cords of E15 Sprague-Dawley rat fe-resulting immunocomplexes were collected by precipitation with
tuses. Spinal cords were dissected, and the meninges and dorsalprotein A–Sepharose CL-4B (Pharmacia). The immunoprecipitates
root ganglia were removed. The spinal cords were cut into smallerwere washed three times with the lysis buffer and once with 0.5%
fragments and digested with papain in L15 medium (Papain Kit,
NP-40 containing 50 mM NaCl and 20 mM Tris–Cl (pH 7.5) and then
Worthington). Motor neurons, which are larger than other types of
resuspended in SDS–PAGE sample buffer and fractionated by 7.5%
cells included in the dissociated cell suspension, were enriched
SDS–PAGE (1:200 Bis:Acrylamide ratio). using a 6.8% metrizamide gradient (Camu and Henderson, 1992).
Enriched motor neurons residing at the interface between the metri-
Preparation of the Ret–Fc Fusion Protein zamide cushion and the cell suspension were collected, washed,
A cDNA containing the coding region of ret was isolated from a day seeded in tissue culture dishes precoated with poly-L-ornithine and
17 rat placenta cDNA library (D. Wen et al., unpublished data) using laminin at a density of approximately 9 3 104 cells/cm2, and cultured
an oligonucleotide probe corresponding to the first 20 amino acids at 378C.
of the mouse Ret (Iwamoto et al., 1993). The region coding for the
extracellular domain of the Ret receptor (ending with arginine-636) Acknowledgments
was fused in-frame with the DNA encoding the Fc region of human
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